Roenhorst H W, Kallenberg C G, The T H
Department of Clinical Immunology, University Hospital Groningen, The Netherlands.
Clin Exp Immunol. 1988 Dec;74(3):326-32.
Development and maintenance of cellular immunity to cell-associated CMV-antigens (CMVFF) was investigated in non-immunocompromised hosts during the first year (group I, n = 11) and 1 to 5 years (group II, n = 9) after a symptomatic primary CMV infection, as well as in healthy CMV-seropositive controls without a history of CMV disease (group III, n = 28). During the acute phase (0-2 months) of a primary CMV-infection CMVFF-induced lymphocyte proliferation was severely decreased compared to that in the post-illness phase (5-12 months), and to that in groups II and III. After the reconvalescent period (3-4 months) it gradually increased to levels seen in group III. In group II higher responses to CMVFF were found than in group III or during the post-illness phase of a primary infection. In general CMV-virion induced lymphocyte proliferation showed the same pattern of development as the CMVFF-induced lymphocyte response, but during the acute phase (0-2 months) a lack of correlation was observed between lymphocyte proliferation to CMVFF and CMV-virions. Lymphocyte proliferation to PHA, Con A, allogeneic lymphocytes and recall antigens were severely depressed in the acute phase of a primary CMV-infection and restored gradually to levels seen in groups II and III, with the exception of Con A-reactivity. The latter response remained depressed when compared to healthy seropositive controls, not only during the post-illness period, but also later on (group II).
在有症状的原发性巨细胞病毒(CMV)感染后的第一年(I组,n = 11)和1至5年(II组,n = 9),以及在无CMV疾病史的健康CMV血清学阳性对照者(III组,n = 28)中,研究了针对细胞相关CMV抗原(CMVFF)的细胞免疫的发育和维持情况。在原发性CMV感染的急性期(0 - 2个月),与疾病后期(5 - 12个月)以及II组和III组相比,CMVFF诱导的淋巴细胞增殖严重降低。恢复期(3 - 4个月)后,其逐渐增加至III组所见水平。在II组中发现对CMVFF的反应高于III组或原发性感染的疾病后期。总体而言,CMV病毒体诱导的淋巴细胞增殖呈现出与CMVFF诱导的淋巴细胞反应相同的发育模式,但在急性期(0 - 2个月),观察到淋巴细胞对CMVFF和CMV病毒体的增殖之间缺乏相关性。在原发性CMV感染的急性期,淋巴细胞对PHA、Con A、同种异体淋巴细胞和回忆抗原的增殖严重受抑,并逐渐恢复至II组和III组所见水平,但Con A反应性除外。与健康血清学阳性对照相比,不仅在疾病后期,而且在之后(II组),后者的反应仍然受抑。